Raymond S.L. Chang
Merck & Co., Inc., Rahway, NJ, USA (United States) · 140 works · 6,206 citations · h-index 35
Top works
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- Benzodiazepine receptors: labeling in intact animals with [3H] flunitrazepam
- A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260
- HETEROGENEITY OF HISTAMINE Hi‐RECEPTORS: SPECIES VARIATIONS IN [3H]MEPYRAMINE BINDING OF BRAIN MEMBRANES
- Histamine H1-receptors in brain labeled with 3H-mepyramine
- Solubilization of histamine H-1, GABA and benzodiazepine receptors
- Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists
- Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: Comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens
- In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia
- Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Structure elucidation.
- Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.
- A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5
- Neurotransmitter receptor localizations: Brain lesion induced alterations in benzodiazepine, GABA, β-adrenergic and histamine H1-receptor binding
- Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted benzolactams
- Histamine H1‐Receptor Binding Sites in Guinea Pig Brain Membranes: Regulation of Agonist Interactions by Guanine Nucleotides and Cations
- Inactivation of angiotensin ii receptors in bovine adrenal cortex by dithiothreitol further evidence for the essential nature of disulfide bonds
- Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 1. Structure−Activity Relationship in Dihydropyrimidinones
- Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions
- Specific [3H]propionyl-neuropeptide Y (NPY) binding in rabbit aortic membranes: Comparisons with binding in rat brain and biological responses in rat vas deferens
- Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists